Mokhtar, G.M., Shaaban, S.Y., Elbarbary, N.S. and Fayed, W.A. (2010) A Trial to Assess the Efficacy of Glutamic Acid in Prevention of Vincristine-Induced Neurotoxicity in Pediatric Malignancies Pilot Study. Journal of Pediatric Hematology Oncology, 32, 594-600.
https://doi.org/10.1097/MPH.0b013e3181e9038d

has been cited by the following article:

• TITLE: Unilateral Ptosis in a Child with Wilm’s Tumor Induced by Vincristine

  AUTHORS: Aziza El Ouali, Karim Lahrache, Zohair El Haddar, Ayad Ghannam, Abdeladim Babakhouya, Maria Rkain, Noufissa Benajiba

  KEYWORDS: Wilms’ Tumor, Vincristine, Neuropathy, Ptosis

  JOURNAL NAME: Journal of Cancer Therapy, Vol.13 No.12, December 28, 2022

  ABSTRACT: Vincristine is a chemotherapy drug belonging to the group of Vinca alkaloids which also includes vinblastine and vindesine. It is used in hematological malignancies and solid tumors. The Vinca alkaloids are neurotoxic, usually causing peripheral neuropathy, and rarely cranial neuropathies. We report a case of a 33-month-old male child diagnosed with Wilms’ tumor, who had an isolated unilateral right ptosis following vincristine, with a good improvement after stopping it.